AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Sperotto, A Zaja, F Damiani, D Patriarca, F Geromin, A Fanin, R
Citation: A. Sperotto et al., High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience, HAEMATOLOG, 86(12), 2001, pp. 1317-1318

Authors: Zaja, F Russo, D Fuga, G Michelutti, T Sperotto, A Fanin, R Baccarani, M
Citation: F. Zaja et al., Rituximab in a case of cold agglutinin disease, BR J HAEM, 115(1), 2001, pp. 232-233

Authors: Patriarca, F Silvestri, F Fanin, R Zaja, F Sperotto, A Baccarani, M
Citation: F. Patriarca et al., Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment, BR J HAEM, 112(2), 2001, pp. 370-372

Authors: Fanin, R Sperotto, A De Elvira, CR Zaja, F Stocchi, R Geromin, A Cerno, M Patriarca, F Canelles, MF Damiani, D Baccarani, M
Citation: R. Fanin et al., A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission onoutcome, HAEMATOLOG, 85(9), 2000, pp. 943-951

Authors: Patriarca, F Gaidano, G Capello, D Zaja, F Fanin, R Baccarani, M
Citation: F. Patriarca et al., Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical responseto autologous stem cell transplantation, HAEMATOLOG, 85(9), 2000, pp. 982-985

Authors: Patriarca, F Damiani, D Fanin, R Grimaz, S Geromin, A Cerno, M Sperotto, A Silvestri, F Zaja, F Baccarani, M
Citation: F. Patriarca et al., High-dose therapy in multiple myeloma: effect of positive selection of CD34(+) peripheral blood stem cells on hematologic engraftment and clinical outcome, HAEMATOLOG, 85(3), 2000, pp. 269-274

Authors: Zaja, F Russo, D Fuga, G Perella, G Baccarani, M
Citation: F. Zaja et al., Rituximab for myasthenia gravis developing after bone marrow transplant, NEUROLOGY, 55(7), 2000, pp. 1062-1063

Authors: Silvestri, F Ermacora, A Sperotto, A Patriarca, F Zaja, F Damiani, D Fanin, R Baccarani, M
Citation: F. Silvestri et al., Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation, BR J HAEM, 108(2), 2000, pp. 394-396

Authors: Fanin, R Sperotto, A Silvestri, F Cerno, M Geromin, A Stocchi, R Infanti, L Patriarca, F Zaja, F Damiani, D Baccarani, M
Citation: R. Fanin et al., The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: Results of 40 cases treated in a single center, LEUK LYMPH, 35(1-2), 1999, pp. 159-169

Authors: Patriarca, F Fanin, R Silvestri, F Candoni, A Zaja, F Sperotto, A Geromin, A Baccarani, M
Citation: F. Patriarca et al., Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undertermined significance, LEUK LYMPH, 34(5-6), 1999, pp. 591-596

Authors: Zaja, F Russo, D Marin, L Silvestri, F Ramello, M Baccarani, M
Citation: F. Zaja et al., Delayed and long-lasting complete response to fludarabine in two patients with B-cell chronic lymphocytic leukemia, ANN HEMATOL, 78(9), 1999, pp. 435-436

Authors: Zinzani, PL Magagnoli, M Galieni, P Martelli, M Poletti, V Zaja, F Molica, S Zaccaria, A Cantonetti, AM Gentilini, P Guardigni, L Gherlinzoni, F Ribersani, M Bendandi, M Albertini, P Tura, S
Citation: Pl. Zinzani et al., Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients, J CL ONCOL, 17(4), 1999, pp. 1254-1258

Authors: Baccarani, U Terrosu, G Donini, A Zaja, F Bresadola, F Baccarani, M
Citation: U. Baccarani et al., Splenectomy in hematology. Current practice and new perspectives, HAEMATOLOG, 84(5), 1999, pp. 431-436

Authors: Zaja, F Russo, D Fuga, G Patriarca, F Ermacora, A Baccarani, M
Citation: F. Zaja et al., Rituximab for the treatment of type II mixed cryoglobulinemia, HAEMATOLOG, 84(12), 1999, pp. 1157-1158

Authors: Zinzani, PL Martelli, M Magagnoli, M Zaja, F Storti, S Pavone, E Lauta, VM De Renzo, A Gobbi, M Bocchia, M Ronconi, F Scaramucci, L Gherlinzoni, F Palombi, F Bendandi, M Stefoni, V Borza, PA Cellini, C Mandelli, F Tura, S
Citation: Pl. Zinzani et al., How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens fare in the long-term?, HAEMATOLOG, 84(11), 1999, pp. 996-1001

Authors: Zinzani, PL Storti, S Zaccaria, A Moretti, L Magagnoli, M Pavone, E Gentilini, P Guardigni, L Gobbi, M Fattori, PP Falini, B Lauta, VM Bendandi, M Gherlinzoni, F De Renzo, A Zaja, F Mazza, P Volpe, E Bocchia, M Aitini, E Tabanelli, M Leone, G Tura, S
Citation: Pl. Zinzani et al., Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients, BLOOD, 94(1), 1999, pp. 33-38
Risultati: 1-16 |